ArticleNature communications2024

Inflammasome-targeted therapy might prevent adverse perinatal outcomes of recurrent chronic intervillositis of unknown etiology.

Aurélien Mattuizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.